Overview

Study of VX-770 on Midazolam and Rosiglitazone and the Effect of Fluconazole on VX-770

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to evaluate the effects of VX-770 on Midazolam and Rosiglitazone, and the effect of Fluconazole on VX-770.
Phase:
Phase 1
Details
Lead Sponsor:
Vertex Pharmaceuticals Incorporated
Treatments:
Fluconazole
Ivacaftor
Midazolam
Rosiglitazone